Technological advances in ablation products have been witnessed over the years owing to the increasing number of patients with atrial fibrillation and cancer. This results in the rising demand for catheter ablation procedures and thus, encouraging market players to focus on technical advances for more efficient and safer ablation. Over the last decade, catheter-based ablation devices have been improved for the improvement of not only the durability of the lesion, however, safety profiles, to minimize radiation exposure and shorten procedure time. Some major advances in ablation products include-
TactiCath Contact Force Ablation Catheter, Sensor Enabled
In January 2019, Abbott declared the US FDA approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled. It is a new ablation catheter which is aimed at supporting physicians to effectively and accurately treat atrial fibrillation (AFib). This approval will further widen the cardiac ablation tools portfolio of Abbott Laboratories that combine with the EnSite Precision cardiac mapping system to support physicians developing highly accurate images of the heart during cardiac ablation procedures.
Browse the full report description of "Ablation Devices Market Size, Share & Trends Analysis Report, By Product Type (Radiofrequency, Microwave, Cryoablation, Ultrasound, and Others), By Application (Cancer, CVD, Ophthalmology, Gynecology, Orthopedics, Urology, and Others), and Forecast, 2019-2025" at https://www.omrglobal.com/industry-reports/ablation-devices-market
The catheter can deliver more precise heart images covered with real-time electrical activity information. It also uses the cutting-edge ergonomic design which is found in Abbott’s FlexAbility ablation catheter for more effective reach and manoeuvrability during the cardiac ablation procedure. The Abbott TactiCath SE ablation catheter can provide an extremely powerful and easy to use, integration of innovative technologies for improvement of ablation procedures. As a large number of physicians focusing on cardiac ablation for the treatment of AFib, the company is focusing on providing such physicians with the highly innovative ablation catheters along with the most cutting-edge cardiac mapping on the market. As the prevalence of AFib is increasing, the demand for such kinds of catheters is anticipated to grow significantly, which in turn, will propel the global ablation devices market.
Stereotaxis and Osypka-partnership to advance robotic catheter technology
In May 2019, Stereotaxis, a provider of advanced robotic technologies to treat cardiac arrhythmias, and Osypka AG, a manufacturer of interventional products, declared a wide strategic partnership to design and develop a next-generation magnetic ablation catheter to be navigated with the use of Stereotaxis’ robotic technology. In addition, the collaboration between companies is intended for the development of electrophysiology products. The accuracy, safety, and effectiveness of current magnetic ablation catheters have been significantly shown in clinical literature and commercial use.
This advanced magnetic ablation catheter is being produced by considering three primary designs, such as improving the placement and quantity of magnetic material in the catheter for the improvement of navigation efficiency and improving the performance and capabilities of the radiofrequency ablation tip. This partnership accelerates the highly complementary strengths of both firms and would enable to intensely improve the clinical effect in electrophysiology and advance patient care and the physician experience in electrophysiology. These kinds of partnerships and developments in electrophysiology products are supporting to drive the demand for catheter ablation products for a more reliable and safer procedure and thereby will likely to drive the global ablation devices market.
Ablation Devices Market Segmentation
By Product Type
By Application
Ablation Devices Market – Segment by Region
North America
Europe
Asia-Pacific
Rest of the World